Group One Trading, L.P. Recursion Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 124,841 shares of RXRX stock, worth $862,651. This represents 0.03% of its overall portfolio holdings.
Number of Shares
124,841Holding current value
$862,651% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$194 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$184 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$149 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$120 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$106 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.25B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...